Albireo Pharma, Inc. announces on January 3, 2022, Roger A. Jeffs, Ph.D, a member of the board of directors of the company, resigned effective as of January 3, 2022 to pursue other opportunities.
Albireo Pharma, Inc.
Equities
ALBO
US01345P1066
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+16.29% | 122B | |
+17.48% | 114B | |
+19.62% | 25.71B | |
-25.81% | 19.02B | |
-20.21% | 15.83B | |
-20.33% | 15.32B | |
-47.37% | 14.88B | |
+60.69% | 14.82B | |
+4.44% | 14.1B |